Catherine Coffey Ross

Catherine Coffey Ross has a strong background in the biopharmaceutical industry, with experience in both commercial and medical affairs roles. Catherine currently serves as the Vice President of Commercial Development at Arbutus Biopharma Corporation, where they have been since April 2023. Prior to this, Catherine worked at Eiger BioPharmaceuticals as a Vice President/Consultant from November 2022 to April 2023. Catherine also held the position of Vice President of Medical Affairs at Antios Therapeutics from August 2021 to September 2022.

Before their roles at Arbutus Biopharma, Eiger BioPharmaceuticals, and Antios Therapeutics, Catherine worked at AbbVie. At AbbVie, they held several positions, including Director of Global Business Development from July 2020 to August 2021, Director of Marketing from November 2015 to July 2020, and Senior Product Manager, HCV from January 2013 to November 2015.

Prior to joining AbbVie, Catherine gained experience at Abbott Laboratories, where they served as a Senior Product Manager, HCV from October 2010 to January 2013 and as a Senior District Business Manager, Virology from February 2004 to October 2010.

Catherine's career in the biopharmaceutical industry began at Roche Pharmaceuticals, where they worked as an HCV Clinical Specialist from October 2000 to January 2004.

Catherine Coffey Ross attended Texas Christian University, but no degree, field of study, or specific duration of attendance is provided.